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ASSOCIATIONS BETWEEN SUBSTANCE USE
DISORDERS AND SUICIDE MORTALITY RISK
SHOULD BE ADJUSTED FOR TOBACCO USE
DISORDER
In January 2014, Bohnert et al. [1] reported inAddiction an
excess risk of death by suicide in individuals diagnosed with
tobacco use disorder. Their findings derived from a cohort
of the US Veterans Health Administration (VHA) records
and included all individuals who received VHA services in
fiscal year (FY) 2005 and who were alive at the beginning
of FY 2006 (n = 4863086). In an unadjusted, bivariate
model, tobacco use disorder was associated significantly
with an increased risk of suicide [hazard ratio (HR) = 1.88;
95% confidence interval (CI) = 1.76–2.02). After
adjustment for a number of confounders—including
substance use disorders—the association, although
attenuated, remained significant (HR = 1.36; 95%
CI = 1.27–1.46). This paper added strong evidence to the
already well-demonstrated increased independent risk of
suicide death among smokers [2–5].
The reading of the recent paper of Bohnert et al. [6] in
the same journal triggered some level of surprise. The
authors, reportedly using the same database of individuals
who received VHA services in FY 2005 andwhowere alive
at the beginning of FY 2006 (n = 4863086), aimed to
estimate associations between substance use disorders
and suicide. The authors specified HRs between each
alcohol, cocaine, cannabis, opioid, amphetamine, psycho-
stimulant and sedatives use disorders, but not tobacco
use disorder and death by suicide, in unadjusted and
adjusted models. In the adjusted models, adjustment was
made for many possible confounders (age, Charlson
comorbidity index, co-occurring psychiatric conditions
such as depression, schizophrenia, bipolar disorder,
post-traumatic stress disorder and other anxiety disor-
ders) but, astonishingly, not for tobacco use disorder or
smoking.
Thus, the authors demonstrated in 2014 [1] that
tobacco use disorder was associated significantly with
suicide mortality after adjusting for substance use
disorders. The 2017 paper by the same authors [2] using
the same database seems to ignore their own previous
finding.
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RESPONSE TO AUBIN ET AL. (2017)
We appreciate the comments on our paper by Aubin and
colleagues [1], and agree that tobacco use disorder is a po-
tentially important risk factor for suicide. Nonetheless,
given preliminary evidence suggesting potential male–fe-
male differences with respect to other substance use disor-
ders (SUDs) and the risk of suicide, the primary objectives of
our most recent paper [2] were to estimate and compare
other SUD-suicide associations between men and women
in the US Veterans Health Administration (VHA). Within
the paper, we acknowledged that incomplete adjustment
for confounding factors, measured or unmeasured, was a
potential study limitation. We elaborated further that,
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due to power constraints, we were unable to account for
co-occurring SUD diagnoses, which includes tobacco use
disorder. Nonetheless, in order to address the specific con-
cerns about tobacco, we ran model 3 including tobacco
use disorder, and findings were only modestly attenuated
and broadly consistent with the prior model 3 findings;
the hazard ratios (HRs) estimating suicide risk associated
with any current SUD were 1.5 [95% confidence interval
(CI) = 1.4–1.6] for men and 1.9 (95% CI = 1.2–2.8) for
women. Overall, it is important to acknowledge that this
study was undertaken to identify markers of risk for suicide
(e.g. to inform providers and health systems), not to neces-
sarily make causal inferences about mechanisms of risk.
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INTELLECTUALLY DISABLED AND ADDICTED:
A CALL FOR EVIDENCE BASED TAILOR-MADE
INTERVENTIONS
At the start of our project, substance use disorders (SUD)
among adults with intellectual disabilities (ID) and
knowledge on SUD in individuals with ID was limited [1].
In recent years, epidemiological studies have emerged,
indicating that this population may be larger than thought
initially. In our study [2] (n = 407, 97%) on SUD almost all
individuals with ID had used alcohol and tobacco at least
once in their lives, and 50% of them had used at least one
illicit substance. The judicial system shows that there is an
over-representation of this group [3]. Data from several
prison populations showed higher ID levels than in the com-
munity (between 10 and 70%), especially among prisoners
with psychiatric disorders [4]. It is estimated that a high per-
centage of SUD is present among prisoners with ID [5].
However, little is known about evidence-based inter-
ventions for SUD in individuals with ID. There are several
reasons for the gap between epidemiological knowledge
and treatment modalities. First, this group is frequently
denied access to the full range of available services, includ-
ing prevention, (early) intervention and aftercare. Sec-
ondly, when individuals with ID are admitted to
substance treatment they are often unable to benefit from
mainstream interventions, due to their limited vocabulary,
poor development of memory function and difficulties dis-
criminating between relevant and irrelevant information.
They experience problems with planning and attention,
have impaired abstract reasoning and low self-insight.
Furthermore, group-based programmes are difficult for
people with ID to participate in because they are often
too abstract, proceed too fast or require adequate social
skills. Therefore, a great need exists for effective, tailor-
made treatment strategies designed for these patients.
In order to bridge the gap between our epidemiological
knowledge and treatment modalities, we conducted a
review of the literature on obstacles for SUD treatment for
individuals with ID, and the opinions of authors regarding
the adaptation of treatment programmes. We found only
six studies, including two randomized studies, that provide
data regarding a treatment modality, covering a total of
148 participants world-wide. The overall conclusions of
these reviewed studies are that the substance-related
knowledge increased, but failed to impact substance-
related attitudes, intention to stop using or the substance
use itself. The interventions are often too short and do
not take into account the complex nature of SUD in ID.
We conclude that almost no new insights were presented
between 1980 and 2015.
This provides food for thought that the lack of adequate
treatment modalities might lead to societal exclusion, and
even criminalization, of this group [6]. This leads to an
extremely problematic situation, as there is apparently lack
of attention from scholars, clinical agencies, donors and
governmental-funded bodies to invest in the development
and adaptation of evidence-based treatment modalities
for this group.
The co-occurrence of SUD and ID thus calls for scien-
tific collaboration between addiction care and intellectual
disability services. By illustrating the gap of research, we
aim to spark future research and we will take the initiative
to collaborate with the clinical and research community to
combine the effort of researching SUD and ID. Further, we
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